🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Paul Tudor Jones’s ETRA Holdings & Trades

First Buy
Q3 2026
Duration Held
1 Quarters
Largest Add
Q3 2026
+13,354 Shares
Current Position
13,354 Shares
$150,233 Value

Paul Tudor Jones's ETRA Position Overview

Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 13,354 shares of Electra Therapeutics, Inc. (ETRA) worth $150,233, representing 0.00% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.

Based on recent 13F filings, Paul Tudor Jones has initiated a new position in ETRA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

Paul Tudor Jones's Electra Therapeutics (ETRA) Holding Value Over Time

Track share changes against reported price movement

Quarterly Electra Therapeutics (ETRA) Trades by Paul Tudor Jones

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +13,354 New Buy 13,354 $11.25

Paul Tudor Jones's Electra Therapeutics Investment FAQs

Paul Tudor Jones first purchased Electra Therapeutics, Inc. (ETRA) in Q3 2026, acquiring 13,354 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Paul Tudor Jones has held Electra Therapeutics, Inc. (ETRA) for 1 quarters since Q3 2026.

Paul Tudor Jones's largest addition to Electra Therapeutics, Inc. (ETRA) was in Q3 2026, adding 13,354 shares worth $150,233.

According to the latest 13F filing for Q3 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 13,354 shares of Electra Therapeutics, Inc. (ETRA), valued at approximately $150,233.

As of the Q3 2026 filing, Electra Therapeutics, Inc. (ETRA) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.

Paul Tudor Jones's peak holding in Electra Therapeutics, Inc. (ETRA) was 13,354 shares, as reported at the end of Q3 2026.